Blockchain Registration Transaction Record

BioCorRx Inc. Acquires FDA-Approved Opioid Withdrawal Medication LUCEMYRA from USWM LLC

BioCorRx Inc. and USWM LLC partner to acquire LUCEMYRA, an FDA-approved opioid withdrawal medication, offering relief during detoxification. This strategic move reinforces the commitment to combat the opioid crisis and improve access to innovative treatment solutions.

This news matters as it represents a significant step in combating the opioid crisis by providing a non-opioid solution for opioid withdrawal symptoms. The acquisition of LUCEMYRA by BioCorRx Inc. highlights a commitment to expanding addiction treatment offerings and improving access to critical solutions for patients in need.